SCHEMBL6844780

SCHEMBL6844780

Bc1ccc(C(=O)O)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.71
▸ TP53 P04637 1/20 0.71
▸ SRD5A2 P31213 5/20 0.60
▸ CA1 P00915 3/20 0.57
▸ CA2 P00918 3/20 0.57
▸ CA12 O43570 1/20 0.57
▸ CA3 P07451 1/20 0.57
▸ TYR P14679 1/20 0.57
▸ DRD1 P21728 1/20 0.57
▸ CA4 P22748 1/20 0.57
▸ CA6 P23280 1/20 0.57
▸ CA5A P35218 1/20 0.57
▸ CA7 P43166 1/20 0.57
▸ CA9 Q16790 1/20 0.57
▸ CA14 Q9ULX7 1/20 0.57
▸ CA5B Q9Y2D0 1/20 0.57
▸ DAO P14920 1/20 0.55
▸ NAPRT Q6XQN6 1/20 0.55
▸ ALDH1A1 P00352 2/20 0.55
▸ ALOX15 P16050 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL27545311 0.97 TSHR (0.67) TSHRTP53SRD5A2CA1CA2
SCHEMBL26038101 0.92 BCL2L1 (0.60) TSHRTP53SRD5A2CA1CA2
Terephthalic Acid SCHEMBL5053781 0.84 TSHR (1.00) TSHRTP53SRD5A2CA1CA2
Terephthalic Acid SCHEMBL1655 0.84 TSHR (1.00) TSHRTP53SRD5A2CA1CA2
Terephthalic Acid SCHEMBL175823 0.84 TSHR (1.00) TSHRTP53SRD5A2CA1CA2
Terephthalic Acid SCHEMBL2511919 0.84 TSHR (1.00) TSHRTP53SRD5A2CA1CA2
Terephthalic Acid SCHEMBL25381766 0.81 TSHR (0.92) TSHRTP53SRD5A2CA1CA2
Terephthalic Acid SCHEMBL2841691 0.81 TSHR (0.92) TSHRTP53SRD5A2CA1CA2
Terephthalic Acid SCHEMBL17667155 0.81 TSHR (0.92) TSHRTP53SRD5A2CA1CA2
Terephthalic Acid SCHEMBL21443891 0.81 TSHR (0.92) TSHRTP53SRD5A2CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115266678-A Ratio type detection method of SERS active substrate of MOF-based composite gold nanoflowers to histamine 江南大学 2022-11-01 — — CN claimed
CN-112920208-A Boric acid-containing indole aryl sulfone derivative and preparation method and application thereof 山东大学 2021-06-08 — — CN claimed
CN-122010362-A Treatment method of hot galvanizing wastewater 杭州汇能实业有限公司 2026-05-12 — — CN disclosed
WO-2023182317-A1 BORONIC ACID-CONTAINING MODIFIED POLYROTAXANE 国立大学法人熊本大学 2023-09-28 — — WO disclosed
CN-115915807-A Electroluminescent device and display device TCL科技集团股份有限公司 2023-04-04 — — CN disclosed
US-11519011-B2 Conversion of lignin into bioplastics and lipid fuels THE TEXAS A&M UNIVERSITY SYSTEM (US) 2022-12-06 — — US disclosed
CN-112920208-B Boric acid-containing indole aryl sulfone derivative and preparation method and application thereof 山东大学 2022-11-08 — — CN disclosed
CN-111755260-B Self-repairing all-solid-state supercapacitor and preparation method thereof 齐齐哈尔大学 2022-04-05 — — CN disclosed
WO-2021111465-A1 NOVEL PROCESS FOR THE PREPARATION OF ACALABRUTINIB AND ITS INTERMEDIATES NATCO PHARMA LIMITED (IN) 2021-06-10 — — WO disclosed
CN-112920208-A Boric acid-containing indole aryl sulfone derivative and preparation method and application thereof 山东大学 2021-06-08 — — CN disclosed
US-10935495-B2 Detection and analysis method for urine-modified nucleoside based on surface-enhanced resonance Raman spectroscopy FUJIAN NORMAL UNIVERSITY (CN) 2021-03-02 — — US disclosed
US-20070212267-A1 Method and apparatus for performing micro-scale chemical reactions TOTAL SYNTHESIS LTD. (CA) 2007-09-13 — — US disclosed
US-20070212267-A1 Method and apparatus for performing micro-scale chemical reactions TOTAL SYNTHESIS LTD. (CA) 2007-09-13 — — US disclosed
US-20070155730-A1 Benzodiazepine And Benzopiperazine Analog Inhibitors Of Histone Deacetylase METHYLGENE, INC. (CA) 2007-07-05 — — US disclosed
WO-2007070173-A2 CETP INHIBITORS MERCK & CO., INC. (US) 2007-06-21 — — WO disclosed
US-20070135426-A1 LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2007-06-14 — — US disclosed
US-7199149-B2 Monocyclic and bicyclic lactams as factor Xa inhibitors BRISTOL MYERS SQUIBB COMPANY (US) 2007-04-03 — — US disclosed
EP-1748046-A2 Inhibitors of histone deacetylase Methylgene, Inc. (CA) 2007-01-31 — — EP disclosed
CN-1089944-A The N-Benzanilide derivatives GLAXO GROUP LTD (GB) 1994-07-27 — — CN disclosed
CN-1071922-A The N-Benzanilide derivatives GLAXO GROUP LTD (GB) 1993-05-12 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155730-A1 Benzodiazepine And Benzopiperazine Analog Inhibitors Of Histone Deacetylase HDAC5, HDAC4, HDAC3 TSHR 2136/4885TP53 4743/4885SRD5A2 570/4885
US-20070135426-A1 LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS F12, F2, CPB1 TSHR 3581/4885TP53 3112/4885SRD5A2 1079/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback